N6-Methyladenosine modification: a novel pharmacological target for anti-cancer drug development
N6-Methyladenosine (m6A) modification is the most pervasive modification of human mRNA molecules. It is reversible via regulation of m6A modification methyltransferase, demethylase and proteins that preferentially recognize m6A modification as "writers", "erasers" and "reade...
Saved in:
Main Authors: | Yi Niu (Author), Arabella Wan (Author), Ziyou Lin (Author), Xiongbin Lu (Author), Guohui Wan (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2018-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel insights into the interaction between N6-methyladenosine modification and circular RNA
by: Tao Xu, et al.
Published: (2022) -
N6-Methyladenosine (m6A) Modification in Natural Immune Cell-Mediated Inflammatory Diseases
by: Yan Teng, et al.
Published: (2023) -
Interaction between N6-methyladenosine modification and the tumor microenvironment in colorectal cancer
by: Jiali Yao, et al.
Published: (2023) -
Functions of RNA N6-methyladenosine modification in acute myeloid leukemia
by: Xue Zheng, et al.
Published: (2021) -
Emerging roles of the RNA modifications N6-methyladenosine and adenosine-to-inosine in cardiovascular diseases
by: Vilbert Sikorski, et al.
Published: (2022)